NL-OMON47160已完成2 期
A phase 2b Study Evaluating the Efficacy of a Single Injection Autologous Adipose Derived Mesenchymal Stromal Cells in Patients with Knee Osteoarthritis - ADIPOA-2
CHRU Montpellier0 个研究点目标入组 15 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 2 期
- 状态
- 已完成
- 发起方
- 入组人数
- 15
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Observational
入排标准
- 年龄范围
- 18 至 99（—）
入选标准
- •1) Male or female between the ages of 45 and 70, during screening.
- •2) BMI between 20 and 35 kg/m2
- •3) Symptomatic mild to moderate osteoarthritis (OA) of the index knee as defined at baseline by the American college of Rheumatology (ACR):
- •-History of pain in the index knee * 6 months, AND
- •-Kellgren and Lawrence (K-L) Grade 2 or 3 only, on plain radiographs of the index knee (including fixed flexion), AND
- •-Swelling of the index knee evaluated by the investigator
- •4) Must meet the following pain criteria at the time of baseline visit since at least half of the days in the previous month:
- •-Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC) pain subscores * 40 mm on the 0-100 normalised scale
- •-Visual analogis scale (VAS) pain rating of at least 40 on a 100-mm scale
- •-Subject*s global assessment of arthritis status must be fair, poor, or very poor
- •-Subject*s global assessment of the contralateral knee <20 mm by 100-mm using VAS*
- •5) NSAID washout of at least 2 days before screening and baseline
- •6) Written informed consent dated and signed prior to the beginning of any procedures related to the clinical trial
排除标准
- •1) Previous treatments acting on cartilage or bone metabolism (eg, oral or intravenous bisphosphonates <1 year previously, strontium ranelate or teriparatide or raloxifene <7 days prior to selection, and oral glucosamine *1500 mg/day and chondroitin sulphate <3 months previously)
- •2) Has had any trauma of the index knee in the previous 12 months prior to the screening visit
- •3) Has OA of the index knee that meets K-L classification criteria of grade 1 or 4
- •4) Osteoarthritis causing significant pain in any joint other than the identified knee, i.e., pain in hip, back, or contralateral knee (* 20 mm pain) as confirmed by a separate VAS at baseline for any other painful joint concerned
- •5) Prior to the screening visit, has received:
- •-Oral corticosteroid therapy within the previous 3 month, OR
- •-Intramuscular, intravenous or epidural corticosteroid therapy within the previous 6 months, OR
- •-Intra-articular injection of corticosteroids in the index within the previous 6 months, OR
- •-Intra-articular injection of hyaluronic acid in the index knee within the 6 months. OR
- •-Intra-articular injection of platelet rich plasma in the index knee within the 6 months.
- •-Tramadol or Opioids (alone or in combination products) therapy within the previous month
- •6) Inflammatory or other rheumatic diseases defined by clinical examination and previous serum markers (such as rheumatoid arthritis, autoimmune disorder, seronegative spondyloarthritis, gout or pseudogout (defined as acute episodic attacks of swollen, painful joint in a patient with X-ray chondrocalcinosis or CPPD crystals))
- •7) Severe misalignment of the knee (excessive varus or valgus * 8°) at physical examination, as confirmed by standard radiograph
- •8) Severe osteoporosis with previous fractures
- •9) History of joint replacement of the knee or hip within the previous 12 months
- •10) Serious systemic diseases or infectious/inflammatory skin diseases in the area of the affected knee
- •11) Positive serology for HIV, hepatitis B, C and syphilis
- •12) History of cancer or blood dyscrasias, or previous chemotherapy, radiotherapy or immunotherapy
研究者
相似试验
尚未招募
不适用
A phase 3 clinical trial examining the effects of SingINg For breathing in chronic obstructive pulmonary disease (COPD) aNd interstitial lung disease (ILD) pAtientsinterstitial lung diseaseACTRN12621001280897St Vincents Hospital Melbourne140
已完成
1 期
Study on the effect of three single ascending doses of sildenafil citrate oral film compared with placebo on blood pressure in healthy young and elderly malesISRCTN10466893IBSA Institut Biochimique (Switzerland)26
招募中
不适用
A phase 2 clinical trial examining the feasibility of SingINg For breathing in chronic obstructive pulmonary disease (COPD) aNd interstitial lung disease (ILD) pAtientsinterstitial lung diseasechronic obstructive pulmonary diseaseRespiratory - Chronic obstructive pulmonary diseaseRespiratory - Other respiratory disorders / diseasesACTRN12621001274864St Vincents Hospital Melbourne35
招募中
2 期
A phase II study to evaluate the effectiveness of S-1 + Cetuximab for patients with advanced/recurrent colon cancer who cannot undergo intensive therapyadvanced/recurrent colon cancer patients with RAS wild-type tumors who cannot undergo intensive therapyJPRN-UMIN000018484HO HOKKAIDO CANCER CENTER Division of Gastroenterology57
尚未招募
Unknown
A comparative study on the effect of a new singing training on oral functions.JPRN-UMIN000051475Tokyo Medical and Dental University30